Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


2 Am J Respir Crit Care Med
2 Antimicrob Agents Chemother
2 Clin Infect Dis
1 Eur Respir J
1 J Bacteriol
1 J Clin Microbiol
1 J Immunol
4 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Respir Crit Care Med

  1. Erratum: Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling.
    Am J Respir Crit Care Med. 2022;206:800-801.

  2. LINDE LR, Readhead A, Barry PM, Balmes JR, et al
    Tuberculosis Diagnoses Following Wildfire Smoke Exposure in California.
    Am J Respir Crit Care Med. 2022 Sep 14. doi: 10.1164/rccm.202203-0457.
    PubMed         Abstract available

    Antimicrob Agents Chemother

  3. ZOU J, Chen S, Rao W, Fu L, et al
    Population Pharmacokinetic Modeling of Bedaquiline among Multidrug-Resistant Pulmonary Tuberculosis Patients from China.
    Antimicrob Agents Chemother. 2022 Sep 15:e0081122. doi: 10.1128/aac.00811.
    PubMed         Abstract available

  4. LIU F, Gao J, Gao M, Liu Y, et al
    Development and Validation of a Nomogram for Prediction of QT Interval Prolongation in Patients Administered Bedaquiline-Containing Regimens in China: a Modeling Study.
    Antimicrob Agents Chemother. 2022;66:e0203321.
    PubMed         Abstract available

    Clin Infect Dis

  5. BALIASHVILI D, Blumberg HM, Benkeser D, Kempker RR, et al
    Association of treated and untreated chronic hepatitis C with the incidence of active tuberculosis disease: a population-based cohort study.
    Clin Infect Dis. 2022 Sep 22. pii: 6711147. doi: 10.1093.
    PubMed         Abstract available

  6. HUANG HL, Lee JY, Lo YS, Liu IH, et al
    Whole-Blood 3-Gene Signature as a Decision Aid for Rifapentine-based Tuberculosis Preventive Therapy.
    Clin Infect Dis. 2022;75:743-752.
    PubMed         Abstract available

    Eur Respir J

  7. KIM C, Ko Y, Moon JW, Park YB, et al
    Incidence, risk factors, and final causes for misdiagnosis of tuberculosis in the Republic of Korea: a population-based longitudinal analysis.
    Eur Respir J. 2022 Sep 14. pii: 13993003.01461-2022.

    J Bacteriol

  8. SCHROETER KL, Abraham N, Rolfe N, Barnshaw R, et al
    Bacterial Hydratases Involved in Steroid Side Chain Degradation Have Distinct Substrate Specificities.
    J Bacteriol. 2022;204:e0023622.
    PubMed         Abstract available

    J Clin Microbiol

  9. WANG SH, Rajaram MVS, Trollip A, Wu Q, et al
    Novel Automation of an Enzyme-Linked Immunosorbent Spot Assay Testing Method: Comparable Diagnostic Performance of the T-SPOT.TB Test Using Manual Density Gradient Cell Isolation versus Automated Positive Selection with the T-Cell Select Kit.
    J Clin Microbiol. 2022;60:e0055122.
    PubMed         Abstract available

    J Immunol

  10. SHANKARAN D, Arumugam P, Vasanthakumar RP, Singh A, et al
    Modern Clinical Mycobacterium tuberculosis Strains Leverage Type I IFN Pathway for a Proinflammatory Response in the Host.
    J Immunol. 2022 Sep 23. pii: jimmunol.2101029. doi: 10.4049/jimmunol.2101029.
    PubMed         Abstract available

    PLoS One

  11. MVELASE NR, Singh R, Swe Swe-Han K, Mlisana KP, et al
    Pyrazinamide resistance in rifampicin discordant tuberculosis.
    PLoS One. 2022;17:e0274688.
    PubMed         Abstract available

  12. LEDESMA JR, Lurie P, Yorlets RR, Daly G, et al
    Spurious early ecological association suggesting BCG vaccination effectiveness for COVID-19.
    PLoS One. 2022;17:e0274900.
    PubMed         Abstract available

  13. MISRA S, Misra N, Seepamore B, Holloway K, et al
    "I would watch her with awe as she swallowed the first handful": A qualitative study of pediatric multidrug-resistant tuberculosis experiences in Durban, South Africa.
    PLoS One. 2022;17:e0274741.
    PubMed         Abstract available

  14. ACHARYA S, Deshpande P, Asirvatham ES, Palkar A, et al
    Utility of the lateral flow urine lipoarabinomannan tuberculosis assay in patients with advanced HIV disease at antiretroviral therapy centres in Mumbai, India.
    PLoS One. 2022;17:e0273970.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.